The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
kudos to Merck cuz I don't I think the FDA would have approved it don't you not with the tissue that fear and even if they thought they could get it by their lawyers probably told them well mercury you know it's funny amount of people don't remember what happened at Merck with Vioxx sure the failure of the black box warning and I actually I got to tell you that that to me is one example of an overreaction to late versus an appropriate reaction sooner
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.